These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Antiarrhythmic therapy in patients with heart failure]. Faber TS; Zehender M Ther Umsch; 2000 May; 57(5):324-32. PubMed ID: 10859993 [TBL] [Abstract][Full Text] [Related]
4. Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review. Hilleman DE; Bauman AL Pharmacotherapy; 2001 May; 21(5):556-75. PubMed ID: 11349745 [TBL] [Abstract][Full Text] [Related]
5. Significance and control of cardiac arrhythmias in patients with congestive cardiac failure. Singh BN Heart Fail Rev; 2002 Jul; 7(3):285-300. PubMed ID: 12215733 [TBL] [Abstract][Full Text] [Related]
7. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction. Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P Circulation; 2014 Feb; 129(8):848-54. PubMed ID: 24381209 [TBL] [Abstract][Full Text] [Related]
8. T wave alternans for ventricular arrhythmia risk stratification. Gold MR; Spencer W Curr Opin Cardiol; 2003 Jan; 18(1):1-5. PubMed ID: 12496495 [TBL] [Abstract][Full Text] [Related]
9. Implantable cardioverter-defibrillator efficacy in patients with heart failure and left ventricular dysfunction (from the MADIT II population). Zareba W; Piotrowicz K; McNitt S; Moss AJ; Am J Cardiol; 2005 Jun; 95(12):1487-91. PubMed ID: 15950580 [TBL] [Abstract][Full Text] [Related]
10. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists? Stevenson WG; Ridker PM JAMA; 1996 Aug; 276(6):481-5. PubMed ID: 8691557 [TBL] [Abstract][Full Text] [Related]
11. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II. Klein H; Auricchio A; Reek S; Geller C Am J Cardiol; 1999 Mar; 83(5B):91D-97D. PubMed ID: 10089848 [TBL] [Abstract][Full Text] [Related]
12. [Management of ventricular arrhythmia in chronic congestive heart failure]. Pulignano G; Giovannini M; Del Sindaco D; Fera MS; Mazza A; Minardi G; Giovannini E Clin Ter; 1998; 149(4):297-305. PubMed ID: 9866892 [TBL] [Abstract][Full Text] [Related]
13. [Arrhythmia risk stratification in patients with heart failure. Foreword]. Opasich C; Santini M Ital Heart J Suppl; 2001 Dec; 2(12):1263-4. PubMed ID: 11838345 [TBL] [Abstract][Full Text] [Related]
14. Use of traditional and biventricular implantable cardiac devices for primary and secondary prevention of sudden death. Klein MH; Gold MR Cardiol Clin; 2008 Aug; 26(3):419-31, vi-vii. PubMed ID: 18538188 [TBL] [Abstract][Full Text] [Related]
15. [Management of arrhythmias in patients with heart failure]. Le Heuzey JY; Copie X; Piot O; Lavergne T; Henry P; Guize L Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1371-6. PubMed ID: 9864606 [TBL] [Abstract][Full Text] [Related]
17. Arrhythmias and sudden death in heart failure. Stevenson WG; Sweeney MO Jpn Circ J; 1997 Sep; 61(9):727-40. PubMed ID: 9293402 [TBL] [Abstract][Full Text] [Related]
18. Pharmacologic and nonpharmacologic treatment of ventricular arrhythmias in heart failure. Stevenson WG; Sweeney MO Curr Opin Cardiol; 1997 May; 12(3):242-50. PubMed ID: 9243081 [TBL] [Abstract][Full Text] [Related]
19. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator. Klein HU; Goldenberg I; Moss AJ Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691 [TBL] [Abstract][Full Text] [Related]
20. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. Wilkoff BL; Cook JR; Epstein AE; Greene HL; Hallstrom AP; Hsia H; Kutalek SP; Sharma A; JAMA; 2002 Dec; 288(24):3115-23. PubMed ID: 12495391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]